We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Stem Cell Institute (Cellmedicine) Successfully Treats Spinal Cord Injury Patient With Adult Stem Cells

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "Stem Cell Institute (Cellmedicine) Successfully Treats Spinal Cord Injury Patient With Adult Stem Cells"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:

The patient suffered a crush fracture of the L1 vertebral body on May 13th, 2008 after a single propeller engine airplane crash. As a result of the spinal cord injury, the patient had severe neuropathic pain, loss of sexual and bladder function, as well as loss of movement and sensation in the legs.

He was treated on Oct 31-Nov 20, 2008, Jan 21-30, 2009, and July 1-10, 2009 with an adult stem cell protocol. The patient underwent a progressive recovery of sensation, mobility, and sexual and bladder function subsequent to each cycle of stem cell administration. Currently the patient is capable of walking and neuropathic pain diminished substantially.

"The doctors at the Stem Cell Institute have changed my life. After the accident there was no hope. Now I have a new lease on life," said Juan Carlos Murillo Rodriguez, the patient who was treated. "I have recently passed my physical and am flying again as a commercial pilot."

Details of the scientific rationale for the treatment, as well as protocols and outcomes may be found in the peer-reviewed paper "Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report" which was published in the International Archives of Medicine and is available online at http://www.intarchmed.com/content/pdf/1755-7682-3-30.pdf.
"It is my honor that such a team of internationally recognized opinion leaders in the area of stem cells such as Doctors Amit Patel, Michael Murphy and Thomas Ichim have co-authored this publication," said Dr. Jorge Paz Rodriguez, Medical Director of the Stem Cell Institute and co-author of the publication. "By combining our clinical experience with cutting-edge advances in molecular and cellular biology, we believe we have put forth a very innovative protocol that we anticipate will be attempted by other groups."